Dow Chemical and DuPont face a “still very open” outcome from a European Union antitrust review of their $60 billion merger, EU Competition Commissioner Margrethe Vestager said as the companies met with regulators to defend the deal.
Regulators are concerned that the agrochemical industry is already “a very concentrated sector” and that farmers need to have a choice of seeds and crop-protection products, Vestager told Bloomberg TV in an interview Monday. The EU is also examining China National Chemical’s bid for Syngenta AG, which Vestager said was a “very different deal” that also showed the importance of research to develop new products.
“Farmers need innovation as well in these products and that would be something that we will be discussing with the companies moving forward,” Vestager said.
Both deals passed milestones in their EU reviews on Monday, with ChemChina and Syngenta submitting concessions to regulators for the first time. Dow and DuPont defended themselves against EU objections at a closed-door hearing in Brussels attended by BASF SE representatives and trade groups for farmers and the biotechnology industry. Regulators will now give feedback on any remaining concerns, and then the companies can offer concessions to allay any issues.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas